NCT05819814View on ClinicalTrials.gov

Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Change in Cardiovascular Health

NARecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

December 7, 2023

Primary Completion Date

February 1, 2026

Study Completion Date

February 1, 2027

Conditions
Coronary Artery Disease
Interventions
GENETIC

Disclosure of high polygenic risk result for coronary artery disease

The disclosure of a high polygenic risk result for coronary artery disease involves a clinical report coupled with a virtual meeting with a genetic counselor.

Trial Locations (1)

02114

RECRUITING

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Massachusetts General Hospital

OTHER